Abstract
In November 2020, a newly formed working group of the ICH (International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use) published a concept paper [1] outlining the considerations for an update to ICH Q9: Quality Risk Management [2]. In the concept paper, the expert group identified four areas for improvement with respect to the current application of Quality Risk Management (QRM). One of the areas identified as problematic was a ‘lack of clarity in risk-based decision making’. The paper described a ‘lack of clarity on what good risk-based decisionmaking means’. This paper looks at risk-based decision-making and, in particular, whether higher level of formality in decision-making would improve the effectiveness of both QRM and KM within key elements Pharmceutical Quality System (PQS).
Recommended Citation
Mulholland, Valerie and Greene, Anne
(2020)
"Quality Risk Management: Seeking the Diamonds: Making the Case for Improved Formality in QRM Decision-making,"
Level 3:
Vol. 15:
Iss.
2, Article 18.
doi:https://doi.org/10.21427/yfw0-hy89
Available at:
https://arrow.tudublin.ie/level3/vol15/iss2/18
DOI
https://doi.org/10.21427/yfw0-hy89
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 4.0 International License.